Content and data provided by various third parties and Fidelity - Terms of Use

ETF / ETP Details

RELATED RESOURCES

Distributions & Expenses: ARKG

ARK GENOMIC REVOLUTION ETF

32.56up0.93 (2.9402%)

 as of 4:10:00pm ET 06/01/2023

Distributions Recap

(Last 12 months) AS OF --
Ex-Date -- Most Recent Pay Date --
Distribution Yield (TTM) -- Most Recent Distribution Amount --
Potential Capital Gains % (3 year Avg)
AS OF -- 		-- Total Amount (TTM) --

Expenses

Gross Expense Ratio
AS OF 11/30/2022 		0.75%
Net Expense Ratio*
AS OF 11/30/2022 		0.75%
*Net expense ratio shown is net of caps and waivers and Deferred Income Expenses, if any.

Distributions Type by Calendar Quarter Ex-Date

  • DIVIDENDS
  • LONG-TERM CAPITAL GAINS
  • SHORT-TERM CAPITAL GAINS
  • RETURN OF CAPITAL
Distributions in US Dollars
Distributions Quater Chart
4 2021

Dividends and Capital Gains DistributionsAs of --

Currency:USD
Ex-Date NAV at
Distribution		 Long-Term
Capital Gains		 Short-Term
Capital Gains		 Dividend Income Return of Capital Distribution Total
12/29/2021 60.1400 0.382400 -- -- -- 0.382400
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

596432.7.0

© 1998－2023 FMR LLC.

All rights reserved.